Pharmaceutical leaders evaluating oral dissolvable strip technology face a harder question than whether the dosage form is convenient. The real issue is whether the solution can carry clinically meaningful therapies while making medication easier for patients who are poorly served by tablets, capsules and liquid formulations. Children, older adults, patients with neurological or developmental challenges and people receiving care in low-resource settings often encounter barriers that turn a prescribed therapy into an impractical routine. Water may not be available at the right time. Refrigeration may be unreliable. Liquid dosing may create measurement errors. Tablets may be difficult or impossible to swallow. For executives, these are not minor usability issues; they influence adherence, access, safety and the economic performance of a therapy across its lifecycle.
THANK YOU FOR SUBSCRIBING




